BGMS
NASDAQ · Biotechnology
Bio Green Med Solution Inc
$1.05
+0.05 (+5.00%)
Open$1.01
Previous Close$1.00
Day High$1.06
Day Low$1.00
52W High$41.55
52W Low$0.73
Volume—
Avg Volume38.8K
Market Cap5.52M
P/E Ratio—
EPS$-1.86
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+622.9% upside
Current
$1.05
$1.05
Target
$7.59
$7.59
$6.77
$7.59 avg
$11.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.80M | 1.16M | 1.19M |
| Net Income | -7,212,087 | -117,803 | -121,826 |
| Profit Margin | -401.3% | -10.2% | -10.2% |
| EBITDA | -7,508,035 | -246,829 | -223,977 |
| Free Cash Flow | — | -166,595 | -168,575 |
| Rev Growth | — | +16.9% | +20.6% |
| Debt/Equity | — | 0.36 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |